2017
DOI: 10.1021/acschembio.6b00877
|View full text |Cite
|
Sign up to set email alerts
|

The Small Molecule 2-Azido-2-deoxy-glucose Is a Metabolic Chemical Reporter of O-GlcNAc Modifications in Mammalian Cells, Revealing an Unexpected Promiscuity of O-GlcNAc Transferase

Abstract: Glycans can be directly labeled using unnatural monosaccharide analogs, termed metabolic chemical reporters (MCRs). These compounds enable the secondary visualization and identification of glycoproteins by taking advantage of bioorthogonal reactions. Most widely used MCRs have azides or alkynes at the 2-N-acetyl position but are not selective for one class of glycoprotein over others. To address this limitation, we are exploring additional MCRs that have bioorthogonal functionality at other positions. Here, we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
50
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 39 publications
(52 citation statements)
references
References 35 publications
2
50
0
Order By: Relevance
“…Furthermore, this suggests that treating cells with these MCRs will have little effect on the endogenous biosynthesis of UDP‐GlcNAc through the HBP. Finally, we tested the most recent MCRs developed by our lab: UDP‐6AzGlcNAc and UDP‐2AzGlc, which are selective for labeling O‐GlcNAc modifications, and UDP‐6AzGlc, which we recently showed might read out on intracellular O‐glucose modifications (Figure B) . In the case of UDP‐6AzGlcNAc, we saw inhibition in a similar range as UDP‐GlcNAc, thus suggesting that the 6‐azido‐6‐deoxy substitution does not interfere with binding of the UDP‐sugar to the allosteric site.…”
Section: Methodsmentioning
confidence: 81%
“…Furthermore, this suggests that treating cells with these MCRs will have little effect on the endogenous biosynthesis of UDP‐GlcNAc through the HBP. Finally, we tested the most recent MCRs developed by our lab: UDP‐6AzGlcNAc and UDP‐2AzGlc, which are selective for labeling O‐GlcNAc modifications, and UDP‐6AzGlc, which we recently showed might read out on intracellular O‐glucose modifications (Figure B) . In the case of UDP‐6AzGlcNAc, we saw inhibition in a similar range as UDP‐GlcNAc, thus suggesting that the 6‐azido‐6‐deoxy substitution does not interfere with binding of the UDP‐sugar to the allosteric site.…”
Section: Methodsmentioning
confidence: 81%
“…In general, the spectral counts were predicted by Western blot data obtained prior to MS analysis, and appears to reflect general trends in the ability to metabolically label different cell lines. 46 …”
Section: Resultsmentioning
confidence: 99%
“…We were interested in addressing the selectively of MCRs, with the goal of developing reporters that could be used for the analysis of a single class of glycoproteins. We recently demonstrated that changes to the structure of the MCRs could yield reporters that are highly selective for O‐GlcNAcylation, including 6‐azido‐6‐deoxy‐ N ‐acetyl‐glucosamine (6AzGlcNAc) and 2‐azido‐2‐deoxy‐glucose (2AzGlc) . Here, we explored the relationship between MCR metabolism, leading to MCR donor sugar accumulation, and protein incorporation levels.…”
Section: Methodsmentioning
confidence: 99%